Related Experiment Video
Updated: May 29, 2026

A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
Published on: August 8, 2013
The elevated serum S100A8/A9 during acute myocardial infarction is not of cardiac myocyte origin
Chang-Qing Du1, Lin Yang, Jie Han
1Institute of Cardiology, the First Affiliated Hospital, School of Medicine, Zhejiang University, 79 Qing Chun Road, Hangzhou, Zhejiang 310003, People's Republic of China.
Insights
Increased S100A8/A9 proteins after acute myocardial infarction (AMI) do not originate from cardiac myocytes. Studies show ischemia and hypoxia activate NF-kappaB but do not alter S100A8/A9 expression in heart cells.
Area of Science:
- Cardiovascular Biology
- Molecular Cardiology
- Inflammation Research
Background:
- Elevated circulating S100A8/A9 levels are observed in patients post-acute myocardial infarction (AMI).
- The cellular origin of these proteins, specifically cardiac myocytes, following ischemic events remains undetermined.
Purpose of the Study:
- To investigate whether ischemia induces S100A8 and S100A9 expression in cardiac myocytes.
- To determine if cardiac myocytes contribute to the circulating S100A8/A9 pool after myocardial infarction.
Main Methods:
- Western blot analysis and quantitative real-time reverse transcription polymerase chain reaction (qRT-PCR).
- Experiments utilized isolated rat hearts (spontaneously hypertensive and Wistar-Kyoto) subjected to global ischemia.
- Neonatal rat cardiac myocytes were exposed to hypoxic conditions.
Main Results:
- Myocardial S100A8 and S100A9 protein and mRNA levels did not increase following ischemia in either rat model.
- S100A8/A9 protein levels remained unchanged in hypoxic neonatal cardiac myocytes.
- NF-kappaB activation was observed in response to ischemia and hypoxia in a time-dependent manner.
Conclusions:
- Cardiac myocytes are not the source of elevated serum S100A8/A9 concentrations observed after AMI.
- While ischemia/hypoxia activate NF-kappaB in cardiac cells, they do not stimulate S100A8/A9 production within these cells.
Abstract:
Overproduction of circulating S100A8/A9 occurs in patients following acute myocardial infarction (AMI). It remains unclear whether ischemia insult per se induces S100A8 and S100A9 expression in cardiac myocytes or even whether the cardiac myocytes participate as a source of these proteins. In this study, western blot analysis and quantitative real-time reverse transcription polymerase chain reaction were used to test samples obtained from isolated spontaneously hypertensive rat hearts and Wistar-Kyoto rat hearts subjected to global normothermic ischemia and from neonatal Wistar rat cardiac myocytes undergoing hypoxia. Ischemia did not increase the expression of S100A8 and S100A9 proteins and mRNA in the myocardium either from the spontaneously hypertensive rat hearts or the Wistar-Kyoto rat hearts. In addition, the levels of S100A8 and S100A9 proteins were unchanged in the neonatal rat cardiac myocytes undergoing hypoxia. However, both ischemia and hypoxia activated NF-kappaB in ischemic myocardium and in hypoxic cardiac cells in a time-dependent manner. The results suggest that the increased serum S100A8/A9 concentrations following AMI were not of cardiac myocyte origin.
More Related Videos
Related Concept Videos
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome III: Diagnostic Studies
Myocarditis I: Introduction

